Adj EBIT of USD 6.2bn, 2% below cons. (higher D&A on the NCS)Net income negative USD 204m, first time since 2020 (Ørsted MTM and other impairments)Production ~1.5% above cons.MMP guidance revised to USD 400m (vs. previously USD 400m - 800m): Negative EPS impact of ~5%We expect EQNR to underperform peers today
